Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS: ELOX · Delayed Price · USD
0.860
-0.101 (-10.52%)
May 1, 2024, 1:21 PM EDT - Market open
Eloxx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 3 | 4 | 50 | 160 | 280 | 390 | 40 | 6 | 4 | 14 | 15 | Upgrade
|
| Market Cap Growth | - | -92.06% | -68.90% | -42.99% | -28.09% | 878.53% | 535.02% | 40.22% | -67.70% | -9.74% | 274.26% | Upgrade
|
| Enterprise Value | 4 | -2 | 21 | 147 | 273 | 341 | 16 | 7 | 4 | 11 | 9 | Upgrade
|
| PE Ratio | -0.92 | -0.11 | -0.74 | -4.62 | -5.51 | -8.26 | -1.88 | -1.08 | -0.54 | -0.77 | -1.66 | Upgrade
|
| PS Ratio | - | - | - | - | - | - | - | - | 59.61 | 184.54 | 153.33 | Upgrade
|
| PB Ratio | -0.66 | -0.37 | 2.22 | 15.61 | 7.74 | 9.08 | 1.86 | 7.20 | 0.98 | 1.13 | 0.56 | Upgrade
|
| P/FCF Ratio | -0.73 | -0.12 | -1.42 | -5.67 | -7.10 | -12.33 | -2.46 | -3.25 | -1.22 | -1.82 | -2.79 | Upgrade
|
| P/OCF Ratio | -0.73 | -0.12 | -1.42 | -5.67 | -7.11 | -12.42 | -2.50 | -3.26 | -1.22 | -1.88 | -3.15 | Upgrade
|
| EV/Sales Ratio | - | - | - | - | - | - | - | - | 48.80 | 140.07 | 92.21 | Upgrade
|
| EV/EBITDA Ratio | -0.77 | 0.06 | -0.32 | -5.15 | -5.59 | -7.39 | -0.80 | -1.89 | -1.01 | -1.40 | -1.40 | Upgrade
|
| EV/EBIT Ratio | -0.74 | 0.06 | -0.32 | -5.05 | -5.53 | -7.35 | -0.80 | -1.87 | -0.99 | -1.37 | -1.33 | Upgrade
|
| EV/FCF Ratio | -0.79 | 0.06 | -0.59 | -5.22 | -6.93 | -10.79 | -0.97 | -3.45 | -1.00 | -1.38 | -1.68 | Upgrade
|
| Debt / Equity Ratio | -0.29 | -1.26 | 0.60 | 1.18 | 0.44 | 0 | 0 | 0.47 | 0 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | -0.31 | -0.40 | -0.21 | -0.42 | -0.32 | - | - | -0.12 | - | - | - | Upgrade
|
| Debt / FCF Ratio | -0.32 | -0.42 | -0.38 | -0.43 | -0.40 | - | - | -0.21 | - | - | - | Upgrade
|
| Quick Ratio | 0.20 | 0.83 | 4.25 | 2.51 | 4.77 | 6.23 | 7.03 | 0.01 | 2.20 | 4.28 | 3.37 | Upgrade
|
| Current Ratio | 0.24 | 0.87 | 4.37 | 2.63 | 4.89 | 6.45 | 7.16 | 0.10 | 2.66 | 4.79 | 3.96 | Upgrade
|
| Asset Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Interest Coverage | -15.48 | -17.66 | -52.44 | -23.74 | -31.28 | -6795.00 | -474.19 | -17.32 | -21003.72 | -6532.97 | -118.13 | Upgrade
|
| Return on Equity (ROE) | 102.16% | 338.32% | -298.10% | -338.00% | -140.49% | -109.96% | -99.31% | -665.33% | -181.29% | -147.76% | -33.56% | Upgrade
|
| Return on Assets (ROA) | -338.99% | -170.74% | -147.83% | -130.59% | -86.30% | -93.03% | -85.60% | -99.16% | -89.62% | -92.41% | -27.67% | Upgrade
|
| Return on Capital (ROIC) | 134.98% | -1263.55% | -184.20% | -150.24% | -97.27% | -110.85% | -95.45% | -359.29% | -245.47% | -147.87% | -33.28% | Upgrade
|
| Earnings Yield | -740.44% | -914.73% | -134.33% | -21.65% | -18.16% | -12.11% | -53.29% | -92.46% | -184.93% | -130.52% | -60.17% | Upgrade
|
| FCF Yield | -650.39% | -809.37% | -70.64% | -17.64% | -14.08% | -8.11% | -40.62% | -30.75% | -82.22% | -54.94% | -35.84% | Upgrade
|
| Buyback Yield / Dilution | -26.83% | -23.85% | -74.36% | -5.42% | -17.35% | -551.81% | -328.64% | -14.25% | -40.96% | -163.27% | -301.00% | Upgrade
|
| Total Shareholder Return | -26.83% | -23.85% | -74.36% | -5.42% | -17.35% | -551.81% | -328.64% | -14.25% | -40.96% | -163.27% | -301.00% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.